Bausch Health Companies Inc. Other Revenue, Net (Deprecated 2018-01-31)
Bausch Health Companies Inc. (BHC) reported Other Revenue, Net (Deprecated 2018-01-31) of $30.00 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2018-05-08
- Bausch Health Companies Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $30.00M, a 9.09% decline year-over-year.
- Bausch Health Companies Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $33.00M, a 8.33% decline year-over-year.
- Bausch Health Companies Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $33.00M, a 6.45% increase year-over-year.
- Bausch Health Companies Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $33.00M, a 8.33% decline year-over-year.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month |
|---|---|---|---|---|
| 2018-03-31 | $30.00M 10-Q · filed 2018-05-08 | |||
| 2017-09-30 | $33.00M 10-Q · filed 2017-11-07 | $66.00M derived: sum of 2 quarters · filed 2017-11-07 | $99.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $33.00M 10-Q · filed 2017-08-08 | $66.00M 10-Q · filed 2017-08-08 | ||
| 2017-03-31 | $33.00M 10-Q · filed 2018-05-08 | |||
| 2016-09-30 | $36.00M 10-Q · filed 2017-11-07 | $67.00M derived: sum of 2 quarters · filed 2017-11-07 | $103.00M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $31.00M 10-Q · filed 2017-08-08 | $31.50M 10-Q · filed 2016-08-09 | $67.00M 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $36.00M 10-Q · filed 2017-05-09 | $35.50M 10-Q · filed 2016-06-07 | ||
| 2015-09-30 | $38.60M 10-Q · filed 2016-11-09 | $76.00M derived: sum of 2 quarters · filed 2016-11-09 | $120.00M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $37.40M 10-Q · filed 2016-08-09 | $81.40M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $44.00M 10-Q · filed 2016-06-07 | |||
| 2014-09-30 | $33.30M 10-Q · filed 2015-10-26 | $80.30M derived: sum of 2 quarters · filed 2015-10-26 | $115.40M 10-Q · filed 2015-10-26 | |
| 2014-06-30 | $47.00M 10-Q · filed 2015-07-28 | $82.10M 10-Q · filed 2015-07-28 | ||
| 2014-03-31 | $35.10M 10-Q · filed 2015-04-30 | |||
| 2013-09-30 | $35.30M 10-Q · filed 2014-10-24 | $67.50M derived: sum of 2 quarters · filed 2014-10-24 | $97.00M 10-Q · filed 2014-10-24 | |
| 2013-06-30 | $32.20M 10-Q · filed 2014-08-01 | $61.70M 10-Q · filed 2014-08-01 | ||
| 2013-03-31 | $29.50M 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |